Each exhibitor and sponsor of the Community Oncology Conference is an important part of the cancer care system. These organizations provide the tools, technologies, and treatments that practices use to deliver local, affordable, and high-quality care to the majority of patients with cancer in the U.S.
As a sponsor or an exhibitor at the Community Oncology Conference, your brand will have face-to-face contact with 1,900+ attendees, including oncologists/hematologists, practice managers, nurses, payers, employers, advocacy groups, industry stakeholders and more. By supporting the 2024 Community Oncology Conference as an exhibitor or sponsor, you are helping community oncology shape a future where all Americans have access to local, affordable, high-quality cancer care.
There are many sponsorship opportunities available, including exhibiting, hosting an educational advisory board, supporting social functions, conference materials and giveaways, and much more. We cannot do this without the ongoing support of the community.
Each exhibitor and sponsor of the Community Oncology Conference is an important part of the cancer care system. These organizations provide the tools, technologies, and treatments that practices use to deliver local, affordable, and high-quality care to the majority of patients with cancer in the US.
As a sponsor or an exhibitor at the Community Oncology Conference, your brand will have face-to-face contact with 1,900+ attendees, including oncologists/hematologists, practice managers, nurses, payers, employers, advocacy groups, industry stakeholders and more. By supporting the 2024 Community Oncology Conference as an exhibitor or sponsor, you are helping community oncology shape a future where all Americans have access to local, affordable, high-quality cancer care.
There are many sponsorship opportunities available, including exhibiting, hosting an educational advisory board, supporting social functions, conference materials and giveaways, and much more. We cannot do this without the ongoing support of the community.
Check out the Conference Prospectus. Once you’ve decided that you would like to participate or for exhibiting and sponsorship opportunities, email Doug and Johanna to get started. We can’t wait to partner with you at this year’s Community Oncology Conference!
Thank You
To Our EXHIBITORS
Executive Platinum Exhibitors
Amgen
https://www.dll3possibilities.com/
Follow Us
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow us on social media @AstraZeneca.
Follow Us
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
Follow Us
Cardinal Health
Cencora
We are becoming Cencora and will unite our 46,000+ team members under one identity in pursuit of a shared purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.Cencora.com.
Follow Us
Daiichi-Sankyo
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline with the launch of the OncoExTraTM and RiskguardTM tests to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
Flatiron Health®
At Flatiron, we believe learning from the experience of every person with cancer is an imperative—it is the key to accelerating research and continuing to improve the quality of care.
Our vision is to build a world where technology and science close the gap between care and research.
Follow Us
Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, Twitter, Instagram, Facebook, YouTube.
Follow Us
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
McKesson
Follow McKesson
Follow The US Oncology Network
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
Patient Point
PatientPoint® is a leading digital health company that connects patients, healthcare providers and life sciences companies with the right information in the moments care decisions are made. Our solutions are proven to influence patient behavior and improve health outcomes, driving value for all stakeholders. Across the nation’s largest network of connected digital devices in 35,000 physician offices, PatientPoint solutions empower better health for more than 750 million patient visits each year. Learn more at patientpoint.com.
Follow Us
Pharmacyclics
Gold Exhibitors
American Oncology Network, LLC (AON)
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.
Follow Us
Astellas
Astellas Oncology is committed to elevating the standard of cancer care. We focus on developing innovative, targeted therapies for hard-to-treat cancers with limited treatment options, which is where we see the greatest opportunity to help people living with cancer.
Follow Us
BeiGene
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 10,000+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
Follow Us
Eisai Inc.
At Eisai Inc., human health care(hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.
Follow Us
Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn.
Follow Us
Morphosys
Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn.
Follow Us
OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. Our goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. Our 1,000 cancer care providers care for approximately 641,000 patients at more than 350 sites of care nationwide.
Follow Us
Organon
At Organon, we continue to focus on broadening the reach of our products and realizing the greater potential of biosimilars. Built from a legacy foundation, we bring the standards you expect from a global biopharmaceutical company. Your experience matters. The Organon Biosimilars team is focused on providing a customer experience that prioritizes your goals throughout the entire biosimilar experience. We believe that helping more people access biologic therapies is important, and we are working toward that ambition with an unwavering commitment to you.
Pfizer Oncology
Pfizer Oncology is at the forefront of a new era in cancer care. Our industry-leading portfolio and pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecifics and other immunotherapies. Driven by science, we are committed to accelerating breakthroughs to extend and improve the lives of people living with some of the world’s most common cancers.
Follow Us
Pharmacosmos Therapeutics Inc.
Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric® (ferric derisomaltose) injection and through exceptional resources to support this treatment. We are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit us at www.monoferric.com to learn more.
Follow Us
Regeneron
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn.
Follow Us
Silver Exhibitors
AllyOncology
We’re shaking up the status quo because you deserve more from your distributor and GPO. For over 40 years, BioCareSD has been a leading specialty-only distributor devoted to ensuring the right therapies into the right hands at the right time, no matter what it takes. AllyOncology, a member of the AllyGPO family, only serves community oncology practices in the clinic class of trade. Together, we’re passionate about being your ally in preserving the vitality of community-based oncology care. Flexibility, transparency, and innovation are part of our DNA. We’re committed to earning your business every day with personalized, high-touch service and performance that bolsters your growth. Learn more at NewOncologyPartner.com.
Follow Us
American Regent, Inc.
American Regent is committed to US-based manufacturing. To that end, over the last several years we have made significant investments in expanding and modernizing our manufacturing facilities in Ohio and New York. This expansion will nearly double our capacity and allow us to better serve our customers now and in the future.
Speed counts. Flexibility matters. Reliability and quality are paramount. Because patients should never have to wait for the medications they need.
Follow Us
Caris Life Sciences
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets. To learn more, please visit CarisLifeSciences.com.
Follow Us
Edenbridge Pharmaceuticals
Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.
Founded in 2008, we launched our first product in February 2010 and have sold our commercial products through every major channel of the U.S. prescription pharmaceutical supply chain. In addition, we have a robust product development pipeline that includes 505(b)(2) NDAs, ANDAs, and foreign filings.
Follow Us
EMD Serono
Foundation Medicine
Foundation Medicine is a pioneer in molecular profiling for cancer, working to shape the future of clinical care and research. We collaborate with a broad range of partners across the cancer community and strive to set the standard for quality, scientific excellence, and regulatory leadership. Our deep understanding of cancer biology helps physicians make informed treatment decisions for their patients and empowers researchers to develop new medicines. We are driven to help our partners find answers and take action as we work to transform cancer care.
Follow Us
Genentech
Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at gene.com.
Follow Us
Gilead Sciences, Inc.
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Follow Us
GSK
Follow Us
Ipsen
Ipsen’s oncology teams are at the heart of our mission to prolong and improve people’s lives. We focus on selected, common and rare cancers and work with like-minded partners to advance science and deliver new cancer treatments.
LeanTaaS
Follow Us
Neogenomics
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. NeoGenomics offers a differentiated solution driven approach to tumor profiling using multiple modalities to detect genomic alterations in clinically significant driver genes centered on NGS, FISH and IHC.
Follow Us
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.
Follow Us
Oncentric
Follow Us
Servier Pharmaceuticals
Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year.
Servier aims to be a renowned,
focused, and innovative player
in the United States, developing
targeted therapies in oncology.
Springworks Therapeutics
Follow Us
Stemline Therapeutics
Takeda Oncology
Follow Us
Unlimited Systems
Unlimited Systems is a software development company headquartered in Cincinnati, Ohio. With a focus on providing financial management solutions for specialty healthcare practices, with a core principle of creating Meaningful, Measurable, and Sustainable results for our clients. Unlimited Systems began the road to helping practices with their financials through their flagship product, g4 Studio. Unlimited Systems has established deep roots in oncology through this solution and has become the most used practice management system in that sector.
Today, Unlimited Systems provides a platform for a wide range of specialty healthcare practices seeking measurable increases in staff productivity, cash flow, and revenue with their feature product Unlimited Financials. Unlimited Financials is a full-featured revenue cycle platform with detailed analytics and task-driven workflows from start to finish. Specialty healthcare practices using Unlimited Financials can be confident that they will achieve peak financial performance.
Follow Us
Bronze Exhibitors
AbbVie
At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge technologies, and by working together with our partners – scientists, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in treatment across some of the most debilitating and widespread cancers. We are also committed to exploring solutions to help patients obtain access to our cancer medicines. AbbVie’s oncology portfolio now consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 300 clinical trials and more than 20 different tumor types. For more information, please visit http://www.abbvie.com/oncology.
Adaptive Biotechnologies
Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. Adaptive’s goal is to develop and commercialize immune-driven diagnostics and therapeutics tailored to each individual patient.
clonoSEQ® is available as an FDA-cleared in vitro diagnostic (IVD) test service provided by Adaptive Biotechnologies to detect measurable residual disease (MRD) in bone marrow from patients with multiple myeloma or B-cell acute lymphoblastic leukemia (B-ALL) and blood or bone marrow from patients with chronic lymphocytic leukemia (CLL). clonoSEQ is also available for use in other lymphoid cancers and specimen types as a CLIA-validated laboratory developed test (LDT). To review the FDA-cleared uses of clonoSEQ, visit clonoSEQ.com/technical-summary.
Follow Us
ADC Therapeutics
ADC Therapeutics is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs). We have a fully integrated value chain with specialized capabilities unique to the lifecycle of ADCs including research, translational and chemistry, manufacturing and controls. Our robust pipeline is comprised of ADCs in clinical trials for both hematologic and solid tumor cancers. We have a strong, proven technology platform in highly potent PBD-based ADCs and we are expanding our reach to develop next-generation assets.
Our senior leaders are industry veterans with experience in both large pharmaceutical companies and biotechnology startups and our highly skilled global workforce is committed to transforming the lives of patients with cancer.
Follow Us
MJH Life Sciences
MJH Life Sciences provides healthcare professionals with the information and resources they need to optimize patient outcomes. Guided by the twin principles of innovation and entrepreneurial spirit, we are dedicated to improving quality of life through healthcare communications, education, and research. With more than 1500 live and virtual events each year and reach to 500+ strategic partners, MJH Life Sciences delivers trusted information that drives informed decisions across multichannel platforms. MJH Life Sciences is the largest privately held healthcare multimedia company in North America.
Follow Us
Alexion
Follow Us
Annexus Health
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
Follow Us
ASCO Certified
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
Follow Us
Assertio
We are a leading commercial pharmaceutical company bringing differentiated products to patients. We have a robust portfolio of branded prescription neurology, inflammation, oncology, and pain medications. The company has grown through business development including acquisitions, licensing and mergers. We are looking to leverage our commercial excellence to be the partner of choice.
Follow Us
AVEO Oncology
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients.
AVEO’s lead candidate, FOTIVDA® (tivozanib), received U.S. Food and Drug Administration (FDA) approval in March 2021 for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
Follow Us
Azurity Pharmaceuticals
Azurity specializes in providing innovative, high-quality medicines that serve overlooked patients. We supply a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of our medicines are dose-form innovations for patients with needs that are not met by other available products. Our medicines have benefited millions of people.
Follow Us
BrandCare Group
Boehringer Ingelheim
Follow Us
Blueprint Medicines
Canopy
Canopy provides oncology practices with a comprehensive platform for all the care that happens between visits. Canopy’s multi-channel ePRO, remote triage, and program management solutions enable practices to identify and prioritize patients who need help, resolve their issues using intelligent software, and generate new reimbursement streams from high-quality care. For more information, visit www.canopycare.us.
Follow Us
Coherus Biosciences
Coherus is focused on developing and commercializing a diversified portfolio of immuno-oncology therapies. The advancement of multiple clinical stage candidates underscores our commitment to immuno-oncology treatments while the biosimilar business enables us to provide better access to therapy for patients with life-altering illnesses.
CuraScript SD
CuraScript SD provides integrated delivery solutions for the safe & efficient distribution of specialty pharmaceuticals & associated medical supplies. We’ve been caring for those who care for more than a quarter of a century by supplying biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products to a wide range of medical providers.
Follow Us
Eagle Pharmaceuticals
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and Byfavo® and Barhemsys® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
Follow Us
Exelixis, Inc.
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development, and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website: https://www.cabometyx.com
Fennec Pharmaceuticals
Follow Us
Florida Cancer Specialists
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
Follow Us
G1 Therapeutics
GE Healthcare
GE Healthcare
Genomic Testing Cooperative
GTC offers genomic profiling of DNA, cfDNA, RNA and cfRNA for both solid and hematologic cancers to communities everywhere. We have a turn-around time of 5-10 days and a QNS rate of <1%. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. GTC’s testing is NY state approved and covered by Medicare and most insurances. Our RNA sequencing capabilities go beyond just the detection of fusions and include alternative splicing, gene expression, viral RNA for HPV and EBV, T and B cell clonalities and more.
Follow Us
ICU Medical
Follow Us
ImmunoGen
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We are a leader in sleep disorders and epilepsy; further developing in movement disorders and PTSD; and focused on hematologic malignancies and solid tumors. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules, biologics, innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.
Follow Us
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of novel first-in-class drugs for the treatment of cancer and other diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1.
Kite, a Gilead Company
Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, focused on cell therapy to treat and potentially cure cancer. As the global cell therapy leader, Kite has treated more patients with CAR T-cell therapy than any other company. Kite has the largest in-house cell therapy manufacturing network in the world, spanning process development, vector manufacturing, clinical trial production, and commercial product manufacturing. For more information on Kite, please visit www.kitepharma.com.
Meaningful Insights Biotech Analytics (MiBA)
American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce its new data solutions division, Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare A.I. company that gathers and delivers the latest data-driven solutions to improve oncology, research and patient care.
In the dynamic landscape of oncology, substantial volumes of data are collected daily, encompassing critical details about patient outcomes. These insights serve as indispensable resources for informed clinical decision-making, guiding the development of strategic action plans to elevate the standard of patient care. MiBA’s sophisticated platform is tailored to empower key decision-makers, including physicians, health systems, biopharmaceutical companies, and payers, providing them with the essential data and tools necessary for accelerating research, evaluating risks, reducing costs, and enhancing both diagnostic accuracy and personalized treatment plans. These capabilities are integral components of MiBA’s comprehensive suite of services, reflecting commitment to advancing healthcare insights on a broader scale.
Follow Us
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Myriad
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Follow Us
Oncoassist
Created in 2012, ONCOassist is the go-to app for many oncology professionals. It gives them comfort that they can access relevant, up to date tools and content at their fingertips. It is the only mobile first platform that saves time and improves the quality of patient care for frustrated and under pressure oncology HCP’s.
With the advent of genomic sequencing, combined with an aging population, and new therapies. The decision making process for oncology HCP’s is becoming increasingly complex. Unfortunately they have no easy access to the tools and information they need to make an informed decision quickly. This means they use multiple different software and tools to aid their decisions, many of which are not safe and validated. This wastes time & reduces the quality of patient care.
We focus on making ONCOassist easily accessible to all oncology HCP’s by being available across multiple devices(iOS, Android and Desktop) and ensuring safety through CE and FDA compliance.
Such is the need for ONCOassist our community of users are actively engaging with us to help define our future tools based on their burning needs. ONCOassist is improving the delivery of cancer care globally and helping us to reach our goal of leveling the standard of care worldwide.
ONCOASSIST is a registered trademark in the United Kingdom: UK00003276315, Ireland: 256660 and United States: 5,736,518.
Follow Us
Ontada
Ontada®, a McKesson business dedicated to oncology, generates real-world data (RWD) and real-world evidence (RWE) and provides clinical education and provider technology to inform and improve cancer care. For more information, visit ontada.com or follow @OntadaOncology.
Follow Us
Paxman
Investing in scientific testing and development allows Paxman to attain the highest levels of technical precision and clinical efficacy, supported by ongoing clinical trials, research and health service dialogue.
US Centers for Medicare & Medicaid Services (CMS) has reassigned payment for scalp cooling for Medicare claims filed using CPT code 0662T. This treatment has been reassigned to New Technology APC 1520 effective January 1, 2022.
Visit www.paxmanscalpcooling.com for detailed clinical information, www.coldcap.com for our patient guide or e-mail us at HCP@paxmanUSA.com.
Follow Us
Personalis
Follow Us
PharmaEssentia
PharmaEssentia Corporation (TPEx: 6446), based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, the company aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today the company is expanding its global presence with operations in the U.S., Japan, China, and Korea, along with a world-class biologics production facility in Taichung. For more information, visit our website or find us on LinkedIn and Twitter.
Follow Us
Puma Biotechnology, Inc.
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition and development of novel therapeutics for the treatment of cancer.
rater8
rater8 is the leader in healthcare reputation management. Medical practices across 80 specialties use rater8 to effortlessly cultivate 5-star reviews for all of their providers and practice locations, capture patient feedback, and gain real-time insights into practice operations. Designed specifically for the healthcare industry, rater8’s automated review-building algorithm intelligently distributes patient reviews across the top healthcare review sites, creating a polished online image to boost your visibility in search results, outshine your competition, and drive more patients through the door.
Follow Us
SamaCare
SamaCare’s free prior authorization management platform aims to alleviate one of the biggest administrative burdens in healthcare today – prior authorization management – by unifying and automating prior authorization submissions, tracking, and follow-up across all payers and physician-administered drugs. Thereby reducing the administrative workload and preventing human errors caused by manual data entry between systems, ultimately reducing staff burnout and facilitating a better patient experience.
Follow Us
Sanofi
SCiO
SCIO Management Solutions is a revenue cycle management and consulting firm with extensive knowledge in billing for comprehensive cancer centers across the United States. We understand the complexity with the buy-and-bill model of reimbursement and we can implement strategies to minimize the risk and maximize the rewards. We provide expertise to improve revenue recovery through comprehensive auditing and revenue cycle management services. SCIO’s competitive advantage over the other revenue cycle and consulting firms is SCIO’s ability to dynamically customize its service offering. We cater to each of our client’s specific and unique needs by providing an upfront, no cost, no obligation assessment with every proposal.
At SCIO, we are fully committed to all of our clients and view our engagements as partnerships. SCIO works day and night in order to best serve our partners, so our partners can continue to offer the best quality care to all their patients in their communities. Our goal is simple… we can only be as successful as our partners.
Smirta
Smirta is a pioneering digital health company focused on revolutionizing cancer care through innovative technology solutions. With a commitment to optimizing resources and improving operational efficiencies in cancer centers, Smirta offers a comprehensive platform called OncoSmart®.
Product:
OncoSmart® is a cutting-edge digital solution designed to streamline processes and enhance patient care in oncology practices. Leveraging advanced algorithms and data analytics, OncoSmart® empowers healthcare providers to make informed decisions, allocate resources efficiently, and optimize utilization.
Mission:
At Smirta, our mission is to keep our product simple but powerful to improve patient outcomes, and ultimately, make a meaningful impact on the fight against cancer. We are committed to improving access to care in oncology and driving positive change in the healthcare industry.
Future Goals:
As we continue to innovate and expand our product offerings, Smirta aims to scale its operations and reach new heights in the digital health space. We are dedicated to forging partnerships, exploring new markets, and leveraging emerging technologies to drive growth and maximize our impact on cancer care worldwide.
Follow Us
Sobi
Follow Us
Solventum
Taiho Oncology Inc.
For more information, visit https://www.taihooncology.com/, and follow us on LinkedIn and Twitter.
Follow Us
Willow Risk Advisors, Inc
Willow Risk is the endorsed broker and worked closely with COA & The Doctors Company in putting together er the malpractice insurance program for COA members.
Follow Us
Non-Profit
The Association for Value-Based Cancer Care
The Association for Value-Based Cancer Care (AVBCC) fosters the exchange of knowledge among all stakeholders in the oncology ecosystem to ensure that patients with cancer receive care that is optimal and accessible.
Through publications, special events, and our popular annual summit, we advise, educate, and encourage the sharing of current and future-state information among oncology stakeholders.
Thank You
TO OUR SPONSORS
Cipla USA
With a steadfast commitment to improving patient lives, Cipla USA has been a key player in the pharmaceutical industry for over 30 years. Our focus on affordability and quality has allowed us to facilitate access to a diverse range of pharmaceutical products tailored for the acute care space and clinics. Our dedication to oncology is evident through the introduction of pioneering 505(b)(2) oncology products, aligning seamlessly with our overarching ‘Caring for Life’ mission.
Cardinal Health
Cencora
We are becoming Cencora and will unite our 46,000+ team members under one identity in pursuit of a shared purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.Cencora.com.
Follow Us
Cipla USA
With a steadfast commitment to improving patient lives, Cipla USA has been a key player in the pharmaceutical industry for over 30 years. Our focus on affordability and quality has allowed us to facilitate access to a diverse range of pharmaceutical products tailored for the acute care space and clinics. Our dedication to oncology is evident through the introduction of pioneering 505(b)(2) oncology products, aligning seamlessly with our overarching ‘Caring for Life’ mission.
House Rx
House Rx is a healthcare technology and services company focused on making specialty medication more accessible and affordable. The company partners with specialty physicians across the country to enable clinics to adopt or improve a medically-integrated approach to pharmacy care known as “medically integrated dispensing.” By bringing medical and pharmacy care together under one roof, specialty clinics are able to better serve patients, lower the cost of care, and create a better experience for patients and their caregivers.
HUB International
Headquartered in Chicago, Illinois, HUB International is a leading full-service global insurance broker and financial services firm providing risk management, insurance, employee benefits, retirement and wealth management products and services. With more than 17,000 employees in offices located throughout North America, HUB’s vast network of specialists brings clarity to a changing world with tailored solutions and unrelenting advocacy, so clients are ready for tomorrow.
Follow Us
Integra Connect
Integra Connect is a value-based, precision medicine company that leads the industry in RWD and analytics capabilities for oncology. With clinical and claims data, deep expertise and sophisticated technologies, it enables providers, payers, and life sciences companies to improve outcomes, decision-making, performance, and research endeavors.
Follow Us
Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
Integra Connect
Integra Connect is a value-based, precision medicine company that leads the industry in RWD and analytics capabilities for oncology. With clinical and claims data, deep expertise and sophisticated technologies, it enables providers, payers, and life sciences companies to improve outcomes, decision-making, performance, and research endeavors.
Follow Us
Navigating Cancer
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.
Follow Us
Oncentric
Follow Us
Regeneron
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn.
Follow Us
Thyme Care
Thyme Care is the leading value-based cancer care partner, collaborating with payers and providers to transform the experience and outcomes for individuals with cancer. We partner with health plans and risk-bearing entities to provide wraparound clinical navigation to their members with cancer, and build a network of high-value community oncology practices to ensure rapid access for members and tight care coordination, creating a hybrid collaborative care delivery model that guides and supports the entire patient journey.
Thyme Care empowers over 400 oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit www.thymecare.com.
Follow Us
